Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
Iscience|December 20, 2022
A prognostic risk model for glioma patients by systematic evaluation of genomic variationsBaifeng Zhang, Weiqing Wan, Zibo Li, et al.
Biomaterials|June 18, 2016
A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activityZhijian He, Xiaomeng Wan, Anita Schulz, et al.
Journal of the American Chemical Society|February 29, 2024
Hexafluoroisopropanol as a Bioconjugation Medium of Ultrafast, Tryptophan-Selective CatalysisMohammad Nuruzzaman, Brandon M Colella, Chiamaka P Uzoewulu, et al.
Nature Communications|February 24, 2025
RNF167 mediates atypical ubiquitylation and degradation of RLRs via two distinct proteolytic pathwaysMiao He, Zixiao Yang, Luyang Xie, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 26, 2019
NaCl Nanoparticles as a Cancer TherapeuticWen Jiang, Lei Yin, Hongmin Chen, et al.
Cell|May 30, 2020
β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive BehaviorsLauren M Slosky, Yushi Bai, Krisztian Toth, et al.
Translational Psychiatry|January 12, 2021
A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autismNicole R Zürcher, Erin C Walsh, Rachel D Phillips, et al.
Journal of Neuroinflammation|November 19, 2020
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acidsDouglas J Hermes, Ian R Jacobs, Megan C Key, et al.
Nature Biomedical Engineering|February 9, 2026
X-ray activated platinum complex induces DNA damage and enhances cancer immunotherapy through abscopal effectGuiyuan Chen, Xiangxia Li, Yu Huang, et al.
Oncoimmunology|May 1, 2023
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanomaJorge D Oldan, Benjamin C Giglio, Eric Smith, et al.
Pageof 26